Priti Balchandani, PhD
- PROFESSOR | Diagnostic, Molecular and Interventional Radiology
- PROFESSOR | Neuroscience
- PROFESSOR | Psychiatry
Research Topics:Biomechanics/Bioengineering, Brain, Brain Imaging, Epilepsy, Imaging, MRI, Magnetic Resonance Imaging, Mathematical Modeling of Biomedical Systems, Neuroscience
Priti Balchandani, PhD, is a Professor of Diagnostic, Molecular and Interventional Radiology, Neuroscience and Psychiatry. She is the Director of the Advanced Neuroimaging Research Program (ANRP) and Associate Director of the BioMedical Engineering and Imaging Institute (BMEII). Her research has been focused on bridging gap between advanced electrical engineering techniques and medical imaging applications. She applies signals and systems principles to image the human brain in unprecedented detail and with new sources of signal and contrast. She develops novel MRI techniques to visualize detailed anatomy as well as vasculature, neuronal fiber tracts and metabolic characteristics in order to obtain a more complete understanding of the effects of disease on the brain. She has applied these methods to improve epilepsy treatment, guide skull base tumor surgery and study the biological mechanisms underlying psychiatric illness. Her work on overcoming some of the main limitations of operating at high magnetic fields has resulted in several innovative tools with wide applicability for human brain imaging and spectroscopy. These techniques are ultimately applied to improve diagnosis, treatment and surgical planning for a range of neurological diseases and disorders. She is PI on three NIH-funded R01 projects focused on utilizing 7T imaging to help guide diagnosis and treatment of neurological diseases. Dr. Balchandani received her BASc in computer engineering at the University of Waterloo in Canada and her PhD in electrical engineering at Stanford University.
Multi-Disciplinary Training AreasArtificial Intelligence and Emerging Technologies in Medicine [AIET], Neuroscience [NEU], Pharmacology and Therapeutics Discovery [PTD]
BASc, University of Waterloo
MS, Stanford University
PhD, Stanford University
NIH Research Project Grant (R01)New award
NIH Research Project Grant (R01)
NIH Research Project Grant (R01)
NIH Small Business Technology Transfer (STTR)
NIH Pathway to Independence Award
Named Junior Fellow of International Society for Magnetic Resonance in Medicine (ISMRM)
Young Investigators’ Award Finalist at ISMRM
Novel MRI techniques to visualize the brain
Dr. Balchandani’s primary research goal is to develop anatomic, spectroscopic and functional magnetic resonance (MR) imaging tools to elucidate changes in brain structure, metabolism and function in the presence of disease. Her work is focused on the application of signal processing principles to the development of novel radio frequency (RF) pulses and pulse sequences that maximize the information imparted by MR images. She has developed several techniques to harness the power of high-field MR magnets by overcoming physical and hardware limitations in order to visualize the human brain in unprecedented structural and metabolic detail. In addition, she is interested in obtaining a direct window into neuronal activation and function by improving current functional imaging techniques and exploiting the MR signal of nuclei other than hydrogen. Together, these techniques are applied to improve diagnosis, treatment and monitoring of neurological diseases and disorders as well as advance our understanding of the brain in the normal state.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Balchandani during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- RefleXion Medical
- GE HealthCare; Philips Healthcare; Siemens; GE HealthCare; Siemens
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.